2Solymoss BC, Marcil M, Chaour M, et al. Fasting hyperinsulinism, insulin resistance syndrone, and coronary artery disease in men and women. Am J Cardiol, 1995; 76(16):1152.
3Maria Pyorala, Hiettinen H, Laakso M, et al. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men.(The 22-years follow-up results of the helsinki policemen study). Circulation, 1998; 98(5):398.
4Goldberg R, Sacks F, Howard B, et al. Diabetic response to pravastatin during the CARE study. Circulation, 1996; 94(suppl I) :1.
5Horio T, Kohno M, Murakawa K, et al. Increased plasma immunoreactive endothelin-1 concentration in hypercholesterolemic rats. Atherosclerosis, 1991 ; 89 : 239.
6Quyyumi AA, Mulcahy D, Andrews NP, et al. Coronary vascular nitric oxide activity in hypertention and hyperrcholesterolemia. Circulation, 1997; 95(1):104.
7Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins implications for cardiovascular event reduction. JAMA,1998; 279(20) ;27.
8Abdelmouttaleb I, Danchin N, Ilaudo C, et aL C-Reactive protein and coronary artery disease; additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J, 1999; 137(2):346.
9Tse HF, Thambar S, Kwong YL, et al. Safety of catheterbased intramyocardial autologous bone marrow cells implantation for therapeutic angiogenesis. Am J Cardiol, 2006,98( 1 ) :60-62.
10Schumacher B, yon Specht BU, Haberstioh J, et al. The stimulation of neo-angiogenesis in the ischemic heart by the human growth factor FGF. J Cardiovasc Surg (Trino),1998,39(4) :445-453.
